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Introduction
The protein tyrosine phosphatase N1 (PTPN1) gene is
located on chromosome 20q13 and encodes PTP-1B, an
enzyme that negatively regulates the insulin receptor. A total
of eight SNPs in the PTPN1 gene have been reported to
be associated with type 2 diabetes, insulin sensitivity and
other type 2 diabetes related traits either individually or
in combination (Echwald et al. 2002; Mok et al. 2002;
Bento et al. 2004; Palmer et al. 2004). Subsequent replica-
tion studies provided weaker or negative results for asso-
ciation with type 2 diabetes (Florez et al. 2005; Traurig
et al. 2007; Wanic et al. 2007). None of these SNPs have
been studied in Asian Indians who have greater insulin
resistance, increased susceptibility to type 2 diabetes, and a
strong genetic background (Radha and Mohan 2007). Hence,
the present study was designed to investigate the associa-
tion of these eight SNPs: rs941798, rs3787345, rs2230604
(Pro303Pro), rs2282147, rs718049, rs718050, rs16995309
(Pro387Leu) and rs16989673 (1484insG), in the PTPN1
gene with type 2 diabetes in an Asian Indian population from
south India.
Materials and methods
Study subjects
A total of 511 subjects, 249 normal glucose tolerant (NGT)
and 262 type 2 diabetic subjects were selected from the
Chennai Urban Rural Epidemiology Study (CURES), an
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ongoing epidemiological study, conducted on a representa-
tive sample of Chennai city in southern India. The method-
ology of CURES has been published elsewhere (Deepa
et al. 2003). NGT was defined as fasting plasma glucose
<5.6 mmol/L and 2 h postglucose value ≤7.8 mmol/L.
Diabetes was diagnosed if the fasting plasma glucose was
≥7 mmol/L or 2 h postglucose value ≥11.1 mmol/L
(Alberti and Zimmet 1998). Informed consent was obtained
from all subjects who participated in this study and this
study was approved by the institutional ethical committee.
Biochemical analyses were carried out on a Hitachi-912
Autoanalyzer (Hitachi, Mannheim, Germany) using com-
mercial kits (Roche Diagnostics, Mannheim, Germany).
Details of methods used for estimating fasting plasma glu-
cose, serum insulin, serum cholesterol, serum triglycerides,
HDL cholesterol and LDL cholesterol are all mentioned else-
where (Deepa et al. 2003). Insulin resistance was calculated
using the homeostasis model assessment-insulin resistance
(HOMA-IR), using the formula: fasting insulin (μIU/mL) ×
fasting glucose (mmol/L)/22.5 (Matthews et al. 1985).
SNP genotyping
DNA was isolated from whole blood using the phenol–
chloroform method. All SNPs were genotyped by PCR-
RFLP followed by agarose gel electrophoresis. The restric-
tion enzymes that were used for RFLP analysis include AleI
for rs941798, TaaI for rs3787345, BsoBI for rs2230604,
BslI for rs2282147, HhaI for rs718049, HpyCH4III for
rs718050, BfaI for rs16995309, and SacII for rs16989673.
To assure that the genotyping was of adequate quality,
we performed random duplicates in 20% of the sam-
ples. The assays were performed by a technician who was
Keywords. PTPN1 gene; type 2 diabetes; PTPN1 polymorphisms; Asian Indians.
Journal of Genetics, Vol. 90, No. 2, August 2011 323
Dhanasekaran Bodhini et al.
masked to the phenotype and there was 99% concordance in
genotyping.
Statistical analysis
SPSS Windows, version 15.0, was used for statistical anal-
ysis. Data for continuous variables were expressed as
mean±SD. Chi-square test was used to compare the pro-
portions of genotypes or alleles. P values < 0.05 were
considered statistically significant. Linkage disequilibrium
(LD) pattern between the SNPs was analysed using the
software Haploview (Barrett et al. 2005). HAPLOPOP
program (Majumdar and Majumder 1999) was used to
determine the frequencies of the haplotypes. Power was
calculated using PS-Power and Sample Size Calculation,
version 3.0.14 (http://ps-power-and-sample-size-calculation.
software.informer.com/).
Results
The diabetic subjects were older (49 ± 10 years) compared
to the NGT subjects (46 ± 11 years, P = 0.001). BMI (NGT:
23.7 ± 4.6; diabetes: 25.1 ± 4.3 kg/m2, P < 0.001), total
cholesterol (NGT: 4.78 ± 1.0; diabetes: 5.24 ± 1.0 mmol/L,
P < 0.001) and serum triglycerides (NGT: 1.35 ± 0.73; dia-
betes: 2.02 ± 1.42 mmol/L, P < 0.001) were all significantly
higher in type 2 diabetic subjects.
Genotype and allele frequencies of PTPN1 SNPs
The Pro387Leu polymorphism was not found in the 249
NGT and 262 type 2 diabetic subjects genotyped in the
present study. Table 1 shows the genotype and allele
frequency of rest of the seven SNPs genotyped in this study.
The genotypic distributions of all the SNPs were in Hardy–
Weinberg equilibrium. There were no significant difference
Table 1. Genotype and allele frequencies of the SNPs studied in PTPN1 gene.
Genotype Type 2 diabetic subjects (n = 262) NGT subjects (n = 249) HOMA-IR (NGT subjects) P value**
rs941798
GG 67 (25.6%) 60 (24.1%) 1.95 ± 1.57 0.45
GA 141 (53.8%) 126 (50.6%) 2.01 ± 1.35
AA 54 (20.6%) 63 (25.3%) 1.72 ± 1.16
MAF (A allele) 249 (48%) 252 (51%) 0.35
rs3787345
TT 131 (50%) 117 (47%) 2.05 ± 1.49 0.79
TC 106 (40.5%) 107 (43%) 1.81 ± 1.26
CC 25 (9.5%) 25 (10%) 1.81 ± 1.16
MAF (C allele) 156 (30%) 157 (32%) 0.58
rs2230604 (Pro303Pro)
CC 164 (62.6%) 144 (57.8%) 2.06 ± 1.49 0.45
CT 91 (34.7%) 95 (38.2%) 1.77 ± 1.17
TT 7 (2.7%) 10 (4.0%) 1.27 ± 0.67
MAF (T allele) 105 (20%) 115 (23%) 0.26
rs2282147
CC 121 (46.2%) 110 (44.2%) 2.05 ± 1.52 0.60
CT 123 (46.9%) 116 (46.6%) 1.80 ± 1.22
TT 18 (6.9%) 23 (9.2%) 1.93 ± 1.24
MAF (T allele) 159 (30%) 162 (33%) 0.49
rs718049
TT 128 (48.9%) 108 (43.4%) 2.05 ± 1.52 0.44
TC 113 (43.1%) 117 (47.0%) 1.83 ± 1.24
CC 21 (8.0%) 24 (9.6%) 1.80 ± 1.20
MAF (C allele) 155 (30%) 165 (33%) 0.24
rs718050
GG 125 (47.8%) 106 (42.6%) 2.03 ± 1.57 0.51
GA 104 (39.6%) 112 (45.0%) 1.81 ± 1.22
AA 33 (12.6%) 31 (12.4%) 2.17 ± 1.33
MAF (A allele) 170 (32%) 174 (35%) 0.48
rs16989673 (1484insG)
0/0∗ 257 (98.1%) 246 (98.8%) – 0.52
0/G 5 (1.9%) 3 (1.2%) –
G/G – –
MAF (G allele) 5 (1%) 3 (0.7%) 0.77
MAF, minor allele frequency, HOMA-IR, homeostasis assessment model for insulin resistance. ∗Refers to the deletion allele of the
1484insG polymorphism. ∗∗Chi square P value for genotypic and allelic frequency between NGT and type 2 diabetic subjects. None of the
SNPs showed any significant difference when the HOMA-IR levels between the genotypes were compared.
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Table 2. Comparison of haplotype frequencies of the PTPN1 SNPs in NGT and type 2 diabetic subjects.
Haplotypes∗ Type 2 diabetes NGT Observed value of test statistics (z) P values
GTCTG0∗∗ 0.483 0.465 0.280 0.779
ACTCA0 0.162 0.193 −0.632 0.528
ATCTG0 0.145 0.143 0.044 0.968
ACCCA0 0.101 0.095 0.157 0.872
GTCTA0 0.02 0.024
ATTCA0 0 0.018
ATCTA0 0 0.013
GTTTG0 0.013 0
∗Haplotypes for SNPs rs941798, rs3787345, rs2230604, rs718049, rs718050 and 1484insG; ∗∗refers to the
deletion allele of the 1484insG polymorphism (rs16989673).
either in the allele frequency or in the genotypic frequency
among the NGT and type 2 diabetic subjects in any of the
SNPs.
Analysis of the effect of PTPN1 SNPs on clinical and
biochemical parameters
Since PTPN1 polymorphisms are known to influence insulin
sensitivity and that Indians are known to be highly insulin
resistant, we compared the HOMA IR levels of the NGT
subjects stratified based on the PTPN1 SNPs and found
no significant association (table 1). HOMA-IR values for
rs16989673 were not compared because of very low fre-
quency of the heterozygous genotype. When the other bio-
chemical parameters were compared, NGT subjects with TT
genotype of the Pro303Pro (rs2230604) had significantly
lower total serum cholesterol levels (mean ± SD: 4.16 ±
0.9 mmol/L) when compared to CT (4.99 ± 1.0 mmol/L) and
CC genotype (4.96 ± 0.8 mmol/L), the age and sex adjusted
P values were 0.025 for CT vs TT and 0.015 for CC vs TT.
The 95% CI for the difference between the means of choles-
terol levels among CC and CT individuals is (−0.31, 0.25),
that between CT and TT is (0.09, 1.57) and that between CC
and TT is (0.32, 1.28). After multiple testing using Bonfer-
roni, the nominal P value for the association of the TT geno-
type with lower total cholesterol levels as compared to CT
(P = 0.025) and CC (P = 0.015) genotype is not lower than
the Bonferroni threshold of 0.05/8, that is, 0.0062. Hence,
this association finding might not be significant. No signifi-
cant difference in the other biochemical parameters such as
fasting plasma glucose, glycated haemoglobin, HDL choles-
terol, LDL cholesterol and serum triglycerides was observed
when the NGT and type 2 diabetic subjects were stratified
according to the other SNPs.
LD estimation between PTPN1 SNPs and haplotype analysis
LD estimation between the PTPN1 polymorphisms revealed
that the rs2282147 and rs718049 polymorphisms exhibited
strong LD (r2 = 0.90 in NGT and 0.85 in type 2 dia-
betic group). Pairwise LD between the other SNPs was
not high. Six locus haplotypes involving SNPs rs941798,
rs3787345, rs2230604, rs718049, rs718050 and 1484insG
were constructed and analysis was restricted to those haplo-
types which have frequency of at least 0.05 in either cases or
controls (table 2). Among the rs2282147 and rs718049 poly-
morphisms which were in strong LD, rs718049 polymor-
phism was included for the haplotype analysis. GTCTG0,
ACTCA0, ATCTG0 and ACCCA0 of SNPs, rs941798,
rs3787345, rs2230604, rs718049, rs718050 and 1484insG
(rs16989673) were the only four haplotypes which were
found with a frequency >5%. None of the haplotypes
showed any significant difference in the frequency between
the NGT and type 2 diabetic subjects.
Discussion
The failure of the present study to replicate the associa-
tion between the PTPN1 variants and type 2 diabetes can
have several explanations. In the first place, this study was
underpowered with the power ranging from 0.17 to 0.34
to detect an association at significance of 5% for the var-
ious SNPs studied. Secondly, as type 2 diabetes is poly-
genic, genetic variants at multiple loci will contribute in
small effect towards its development and it is possible that
this effect went undetected in the present study because of
the small sample size. Another possibility is that the initial
association signal reported by Bento et al. (2004) is valid,
but there is heterogeneity among the various populations
examined either in the phenotypic characteristics of patients
studied or in the frequencies of genetic or environmental
modifiers.
In the present study, PTPN1 variants do not seem to have
a major role in the aetiology of type 2 diabetes in this pop-
ulation. Since this study is underpowered, elucidation of
these results with much larger sample size may help in bet-
ter understanding of the role of PTPN1 variants in type 2
diabetes.
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